Effect of mitomycin-C on human retinal pigment epithelium in culture

被引:5
作者
Ho, TC
DelPriore, LV
Hornbeck, R
机构
[1] WASHINGTON UNIV,SCH MED,DEPT OPHTHALMOL & VISUAL SCI,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,DEPT BIOCHEM & MOL BIOPHYS,ST LOUIS,MO 63110
[3] NATL TAIWAN UNIV HOSP,DEPT OPHTHALMOL,TAIPEI,TAIWAN
关键词
cell proliferation; mitomycin-C; proliferative vitreoretinopathy; human retinal pigment epithelium (HRPE);
D O I
10.1076/ceyr.16.6.572.5073
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To determine the effect of mitomycin-C on confluent and non-confluent human retinal pigment epithelium (RPE) in tissue culture. Methods. The effect of mitomycin-C on confluent RPE was determined by treating first passage confluent cells with 0.01, 0.1, 1, 10, 100 or 1000 micromolar (mu M) mitomycin-C for 1, 3. or 7 days. The cell viablility after treatment was determined by using an esterase stain. The effect of mitomycin-C on proliferating RPE was determined by incubating non-confluent cells with the above concentrations of mitomycin-C for 20 min, 1 hour or 24 hours. Results. Mitomycin-C can be toxic to a confluent RPE monolayer, and the LD50 is 421, 28.8 or 0.0632 mu M when cells are continually exposed to mitomycin-C for 1, 3 or 7 days, respectively. Exposure to mitomycin-C at concentrations greater than or equal to 10 mu M for 20-60 min significantly inhibits proliferation of non-confluent RPE. A 24 hour exposure of RPE to 1 mu M mitomycin-C markedly inhibits proliferation of non-confluent RPE with minimal toxicity to confluent RPE. Conclusions. Since exposure of human RPE to mitomycin-C for 24 hours can inhibit cell proliferation at concentrations which are well-tolerated by confluent RPE, mitomycin-C may be a suitable agent for inhibiting RPE proliferation in vivo.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 17 条
  • [1] BLUMENKRANZ M, 1984, OPHTHALMOLOGY, V91, P122
  • [2] TRABECULECTOMY WITH SIMULTANEOUS TOPICAL APPLICATION OF MITOMYCIN-C IN REFRACTORY GLAUCOMA
    CHEN, CW
    HUANG, HT
    BAIR, JS
    LEE, CC
    [J]. JOURNAL OF OCULAR PHARMACOLOGY, 1990, 6 (03): : 175 - 182
  • [3] CHEN EP, 1992, INVEST OPHTH VIS SCI, V33, P2160
  • [4] INFLUENCE OF MITOMYCIN-C ON ENDOTHELIAL MONOLAYER REGENERATION INVITRO
    COOMBER, BL
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, 50 (03) : 293 - 300
  • [5] MITOMYCIN-C - REVIEW
    CROOKE, ST
    BRADNER, WT
    [J]. CANCER TREATMENT REVIEWS, 1976, 3 (03) : 121 - 139
  • [6] Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration
    DelPriore, LV
    Kaplan, HJ
    Hornbeck, R
    Jones, Z
    Swinn, M
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 122 (05) : 629 - 643
  • [7] TOXICITY OF MITOMYCIN-C TOWARD CULTURED PULMONARY-ARTERY ENDOTHELIUM
    HOORN, CM
    WAGNER, JG
    PETRY, TW
    ROTH, RA
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 130 (01) : 87 - 94
  • [8] 5-MINUTE TREATMENTS WITH FLUOROURACIL, FLOXURIDINE, AND MITOMYCIN HAVE LONG-TERM EFFECTS ON HUMAN TENON CAPSULE FIBROBLASTS
    KHAW, PT
    SHERWOOD, MB
    MACKAY, SLD
    ROSSI, MJ
    SCHULTZ, G
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (08) : 1150 - 1154
  • [9] ANTIPROLIFERATIVE DRUGS IN THE TREATMENT OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY - CONTROL BY DAUNOMYCIN
    KIRMANI, M
    SANTANA, M
    SORGENTE, N
    WIEDEMANN, P
    RYAN, SJ
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1983, 3 (04): : 269 - 272
  • [10] TRABECULECTOMY WITH MITOMYCIN - A COMPARATIVE-STUDY WITH FLUOROURACIL
    KITAZAWA, Y
    KAWASE, K
    MATSUSHITA, H
    MINOBE, M
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1991, 109 (12) : 1693 - 1698